VU0155041

VU0155041 is an experimental drug that is a positive allosteric modulator for the glutamate receptor mGluR4. In animal studies it has anti-Parkinsonian action, reduces neuropathic pain such as allodynia, and counteracts the effects of opioid addiction.
Wikipedia contributors, "VU0155041", Wikipedia, revision 1370373883, retrieved 20 November 2026, source, CC BY-SA 4.0.